Effect of a Topical Nonsteroidal Anti-Inflammatory Drug (0.1% Pranoprofen) on VEGF and COX-2 Expression in Primary Pterygium. [PDF]
Yao B +6 more
europepmc +1 more source
Subconjunctival injection of bevacizumab for treatment of pterygium
Objective: This study determined the biologic effect and safety of subconjunctival administration of bevacizumab in patients with primary and recurrent pterygium. Methods: We conducted an off-label, multiple-dosing, interventional case series involving
Anthony F. Felipe, MD +2 more
doaj
Corrigendum: Effect of a Topical Nonsteroidal Anti-Inflammatory Drug (0.1% Pranoprofen) on VEGF and COX-2 Expression in Primary Pterygium. [PDF]
Yao B +6 more
europepmc +1 more source
Recurrence rate, time to recurrence, and associated factors after primary pterygium excision with conjunctival-limbal autograft: a prospective cohort study. [PDF]
Pardo-Bayona M +4 more
europepmc +1 more source
Association of serum complement C3 level with disease severity in primary pterygium. [PDF]
Yun YI, Heo JS, Lee SH, Kim KW.
europepmc +1 more source
Optimal Time for Stabilization of Anterior Corneal Keratometry after Primary Pterygium Excision Adjusted for Horizontal Invasion Length. [PDF]
Kim S, Lee SH, Kim KW.
europepmc +1 more source
Extended Tenon Removal Versus Limited Tenon Removal With Conjunctivo-Limbal Autograft in Primary Pterygium Surgery: A Prospective Comparative Study. [PDF]
Sharma J, Gupta RK, Korla S.
europepmc +1 more source
Mini-simple limbal epithelial transplantation and conjunctival-limbal autograft for the treatment of primary pterygium: Study protocol for a randomized controlled trial. [PDF]
Vera-Duarte GR +6 more
europepmc +1 more source

